Design and Optimization of Orally Administered Luteolin Nanoethosomes to Enhance Its Anti-Tumor Activity against Hepatocellular Carcinoma

• Autores principales: Mahmoud M. A. Elsayed (Autor), Tarek M. Okda (Autor), Gamal M. K. Atwa (Autor), Gamal A. Omran (Autor), Atef E. Abd Elbaky (Autor), Abd El hakim Ramadan (Autor)
• Formato: Libro
• Publicado: MDPI AG, 2021-05-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Luteolin (LUT) is a natural flavonoid with low oral bioavailability with restricted clinical applications due to its low solubility. LUT shows significant anti-tumor activity in many cancer cells, including hepatocellular carcinoma (HCC). The most recent trend in pharmaceutical innovations is the ap...